Alterative Expression and Localization of Profilin 1/VASPpS157 and Cofilin 1/VASPpS239 Regulates Metastatic Growth and Is Modified by DHA Supplementation.

作者: Mehboob Ali , Kathryn Heyob , Naduparambil K. Jacob , Lynette K. Rogers

DOI: 10.1158/1535-7163.MCT-16-0092

关键词: Cofilin 1A549 cellCell adhesion moleculeCell biologyBiologyActin remodelingProfilinMetastasisCancer cellCellular localization

摘要: Profilin 1, cofilin and vasodialator-stimulated phosphoprotein (VASP) are actin-binding proteins (ABP) that regulate actin remodeling facilitate cancer cell metastases. miR-17-92 is highly expressed in metastatic tumors profilin1 cofilin1 predicted targets. Docosahexaenoic acid (DHA) inhibits proliferation adhesion. These studies tested the hypothesis phenotype driven by changes ABPs including alternative phosphorylation and/or subcellular localization. In addition, we efficacy of DHA supplementation to attenuate or inhibit these changes. Human lung tissue sections were analyzed for F-actin content expression cellular localization profilin1, cofilin1, VASP (S157 S239 phosphorylation). The was investigated A549 MLE12 cells lines using 8 Br-cAMP as a metastasis inducer therapeutic agent. Migration assessed wound assay measured Western blot confocal analysis. qRT-PCR. Results indicated increased altered distribution profilin1/VASP(pS157), but no cofilin1/VASP(pS239) human malignant tissues compared with normal tissues. cells, patterns profilin1/VASP(pS157) suggested an interaction regulation dynamics. Furthermore, inhibited migration viability, ABP localization, modulated minimal effects cells. Further investigations warranted understand interactions, miR-17-92, novel therapeutic. Mol Cancer Ther; 15(9); 2220-31. ©2016 AACR.

参考文章(53)
J L Cresanta, Epidemiology of cancer in the United States. Primary Care. ,vol. 19, pp. 419- 441 ,(1992)
Kent Hunter, The role of individual inheritance in tumor progression and metastasis Journal of Molecular Medicine. ,vol. 93, pp. 719- 725 ,(2015) , 10.1007/S00109-015-1299-6
Jin-Liang Ma, Wei-Dong Jia, Ji-Hai Yu, Si-Nan Sun, Jian-Sheng Li, Hao Chen, Yong-Sheng Ge, Docosahexaenoic acid (DHA) induces apoptosis in human hepatocellular carcinoma cells International Journal of Clinical and Experimental Pathology. ,vol. 6, pp. 281- 289 ,(2013)
Campbell W. Gourlay, Kathryn R. Ayscough, The actin cytoskeleton: a key regulator of apoptosis and ageing? Nature Reviews Molecular Cell Biology. ,vol. 6, pp. 583- 589 ,(2005) , 10.1038/NRM1682
Jing Li, Sheng Yang, Wen Yan, Jie Yang, Yu-Juan Qin, Xiao-Lin Lin, Rao-Ying Xie, Sheng-Chun Wang, Wen Jin, Fei Gao, Jun-Wen Shi, Wen-Tao Zhao, Jun-Shuang Jia, Hong-Fen Shen, Jie-Rong Ke, Bin Liu, Yi-Qiao Zhao, Wen-Hua Huang, Kai-Tai Yao, Dan-Juan Li, Dong Xiao, MicroRNA-19 triggers epithelial–mesenchymal transition of lung cancer cells accompanied by growth inhibition Laboratory Investigation. ,vol. 95, pp. 1056- 1070 ,(2015) , 10.1038/LABINVEST.2015.76
Rebecca Siegel, Elizabeth Ward, Otis Brawley, Ahmedin Jemal, Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA: A Cancer Journal for Clinicians. ,vol. 61, pp. 212- 236 ,(2011) , 10.3322/CAAC.20121
Nayeong Kim, Soyeon Jeong, Kaipeng Jing, Soyeon Shin, Soyeon Kim, Jun-Young Heo, Gi-Ryang Kweon, Seung-Kiel Park, Tong Wu, Jong-Il Park, Kyu Lim, Docosahexaenoic Acid Induces Cell Death in Human Non-Small Cell Lung Cancer Cells by Repressing mTOR via AMPK Activation and PI3K/Akt Inhibition BioMed Research International. ,vol. 2015, pp. 239764- 239764 ,(2015) , 10.1155/2015/239764
Rena Chiotaki, Hara Polioudaki, Panayiotis A. Theodoropoulos, Differential nuclear shape dynamics of invasive andnon-invasive breast cancer cells are associated with actin cytoskeleton organization and stability. Biochemistry and Cell Biology. ,vol. 92, pp. 287- 295 ,(2014) , 10.1139/BCB-2013-0120
Ronit Cohen, Eyal Greenberg, Yael Nemlich, Jacob Schachter, Gal Markel, miR-17 regulates melanoma cell motility by inhibiting the translation of ETV1. Oncotarget. ,vol. 6, pp. 19006- 19016 ,(2015) , 10.18632/ONCOTARGET.4147